脑出血患者中Takotsubo心肌病的发生率:一项美国全国性研究
该研究基于美国全国住院患者样本(Nationwide Inpatient Sample)2015—2018年数据,按是否诊断Takotsubo心肌病对脑出血患者分层。结果显示脑出血出院患者中Takotsubo心肌病发生率为0.27%(95%CI 0.24-0.31)。Takotsubo心肌病组女性更多(OR 3.65,95%CI 2.63-5.05),急性心肌梗死更多(OR 7.91,95%CI 5.80-10.80),死亡率33.48%(p<0.0001),住院时间延长(15.72±13.56天 vs 9.56±14.10天,p<0.0001)。脑室内出血患者发生Takotsubo心肌病的比值比最高(OR 2.46,95%CI 1.88-3.22)。
要点
- 脑出血患者中Takotsubo心肌病发生率为0.27%(95%CI 0.24-0.31)。
- 合并Takotsubo心肌病的脑出血患者死亡率33.48%(p<0.0001),显著高于未合并者。
- 合并Takotsubo心肌病者住院时间更长:15.72±13.56天 vs 9.56±14.10天(p<0.0001)。
- 脑室内出血患者发生Takotsubo心肌病的OR为2.46(95%CI 1.88-3.22),比值比最高。
- Takotsubo心肌病组女性更多(OR 3.65,95%CI 2.63-5.05),急性心肌梗死更多(OR 7.91,95%CI 5.80-10.80)。
适用人群与场景
- 2015—2018年美国全国住院患者样本中出院的脑出血患者。
研究设计与关键结果
- 研究类型:基于美国全国住院患者样本(Nationwide Inpatient Sample)的全国性研究;人群为2015—2018年出院的脑出血患者,按是否诊断Takotsubo心肌病分层。
- 脑出血出院患者中Takotsubo心肌病发生率为0.27%(95%CI 0.24-0.31)。
- 发生Takotsubo心肌病的脑出血患者平均年龄66.28岁±17.11。
- Takotsubo心肌病组女性显著更多,OR 3.65(95%CI 2.63-5.05)。
- Takotsubo心肌病组急性心肌梗死显著更多,OR 7.91(95%CI 5.80-10.80)。
- 合并Takotsubo心肌病的脑出血患者死亡率显著更高,为33.48%(p<0.0001)。
- 合并Takotsubo心肌病的脑出血患者住院时间显著延长:15.72±13.56天 vs 9.56±14.10天(p<0.0001)。
- 脑室内出血患者发生Takotsubo心肌病的OR为2.46(95%CI 1.88-3.22),为最高。
证据类型、等级与局限
- 证据类型:基于全国住院患者样本的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,Takotsubo心肌病与脑出血患者更高的死亡率、更长的住院时间和更多的急性心肌梗死相关。
- 作者指出,脑室内出血与更高的Takotsubo心肌病发生比值比相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Takotsubo cardiomyopathy (TC) is a commonly observed complication among patients with intracerebral hemorrhage (ICH); however, the incidence of TC in patients with ICH have not been investigated yet. The goal of this study was to examine the incidence of TC in ICH and identify its risk factors, incidence rate, and outcomes of TC in patients with ICH in a US nationwide scale.
METHODS: Data for patients with ICH between the years of 2015 and 2018 were extracted from the Nationwide Inpatient Sample and stratified based on the diagnosis of TC.
RESULTS: Our results showed that the incidence rate of TC in ICH discharges was 0.27% (95% confidence interval [CI] 0.24-0.31). The mean age of patients with ICH developing TC was 66.28 years ± 17.11. There were significantly more women in the TC group, with an odds ratio (OR) of 3.65 (95% CI 2.63-5.05). Acute myocardial infarction (OR 7.91, 95% CI 5.80-10.80) was significantly higher in the TC group. The mortality rate of patients with ICH who had TC was significantly higher (33.48%, p < 0.0001). Length of stay (mean days; 15.72 ± 13.56 vs. 9.56 ± 14.10, p < 0.0001) significantly increased in patients with ICH who had TC. Patients with intraventricular ICH (OR 2.46, 95% CI 1.88-3.22) had the highest odds of TC.
CONCLUSIONS: Takotsubo cardiomyopathy is associated with a higher mortality, longer hospitalization period, and more acute myocardial infarctions in patients with ICH. It is illustrated that intraventricular ICH is associated with higher odds of TC.
参考来源
- Mirmoeeni S, Azari Jafari A, Lacci JV, et al. The Incidence of Takotsubo Cardiomyopathy in Patients with Intracerebral Hemorrhage: A US Nationwide Study. Neurocrit Care. 2022. PMID: 36138271. doi:10.1007/s12028-022-01598-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。